Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Duration Artemether-lumefantrine Treatment for Malaria in Children

NCT03453840 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03453840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03453840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Duration Artemether-lumefantrine Treatment for Malaria in Children
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
February 21, 2018
Completion date
August 31, 2021
Enrollment
305 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

uncomplicated plasmodium falciparum malaria